Jelena Šurlan

Mrs. Jelena Šurlan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2023 in Food Hydrocolloids
Verified
Journal Article
Closed access
JŠJelena Šurlan
Jelena Šurlan
ZŠZita Šereš
Zita Šereš
LDLjubica Dokić
Ljubica Dokić
Veljko KrstonošićVeljko Krstonošić
Veljko Krstonošić
NMNikola Maravić
Nikola Maravić

27 November 2025 in Membranes
Verified
Journal Article
Open access
PDF file
JŠJelena Šurlan
Jelena Šurlan
CGClaudia F Galinha
Claudia F Galinha
NMNikola Maravić
Nikola Maravić
Carla BrazinhaCarla Brazinha
Carla Brazinha
IAIgor Antić
Igor Antić
JCJoão G. Crespo
João G. Crespo
Pharmaceutically active compounds (PhACs), pesticides, and poly- and perfluoroalkyl substances (PFAS) are increasingly detected in surface waters at trace concentrations, raising concerns for both aquatic systems and, consequently, human health. Conventional solutions are insufficient to achieve complete removal at trace compound concentrations, highlighting the need for advanced separation technologies. This study aims to comprehensively analyze rejection and removal mechanisms of selected PhACs, pesticides, and PFAS present in water solutions at reported environmentally relevant concentrations (300 ng L−1), using two nanofiltration (NF) and one reverse osmosis (RO) polyamide membrane. PhACs, pesticides, and PFAS were selected to cover a broad range of physicochemical properties, specifically molecular mass (MM), dissociation constant (pKa), and octanol–water partition coefficient (logKo/w). Rejection values ranged from 42.1% (acetaminophen) to apparent 100% (for multiple compounds), depending on water pH, solute properties, and membrane characteristics. Size exclusion and electrostatic interactions were identified as the primary removal mechanisms, with hydrophobic interactions having a lower impact, particularly for carbamazepine, bezafibrate, and perfluorooctane sulfonic acid (PFOS). Addition of sodium chloride (3 g L−1) decreased rejection of most negatively charged compounds due to suppression of membrane surface charge, although clarithromycin and ofloxacin exhibited improved rejection. Presented results provide fundamental insight into compound-specific membrane rejection and highlight the importance of membrane–solute interactions under environmentally realistic conditions. The results support further optimization of NF and RO for targeted compound rejection and provide a baseline for data-driven membrane process modeling.